Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.4096
+0.0236 (6.11%)
Aug 14, 2026, 2:23 PM EDT - Market open
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $19.91 million as of August 14, 2026. Its market cap has decreased by -67.14% in one year.
Market Cap
19.91M
Enterprise Value
-2.08M
1-Year Change
-67.14%
Ranking
Category
Stock Price
$0.41
ChartMarket Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $19.91M, a decrease of -95.48%. That is a compound annual growth rate of -44.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 19.91M | -35.26% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 20.67M |
| Neuphoria Therapeutics | 20.59M |
| Atossa Therapeutics | 20.50M |
| Celularity | 20.29M |
| Marker Therapeutics | 19.60M |
| Skye Bioscience | 19.33M |
| Tempest Therapeutics | 19.18M |
| Polyrizon | 19.15M |